Medical research

This undated photo provided courtesy of Anisha Khanna, shows, from left, Anisha, Sughanda, Kamlesh, Satyender and Priya Khanna. The northern New Jersey family of five doctors has lost two members to COVID-19. Satyender Khanna, who died at 77, was a practicing surgeon for more than four decades. His daughter, Priya Khanna, who died at 43, specialized in the study of kidney diseases.  (Courtesy of Anisha Khanna via AP)
1010 WINS Newsroom
June 09, 2020 - 1:01 am
NEW YORK (AP) — Priya Khanna may have been destined to practice medicine all along, and not necessarily because she grew up in a family of doctors. The middle daughter of a surgeon and pediatrician who had immigrated from India and settled in northern New Jersey in the early 1970s, Khanna tested...
Read More
FILE - This Monday, April 6, 2020 file photo shows an arrangement of hydroxychloroquine pills in Las Vegas. On Friday, June 5, 2020, leaders of a large study in the United Kingdom that is rigorously testing the malaria drug hydroxychloroquine and other medicines for hospitalized COVID-19 patients say they will stop putting people on the drug because it’s clear it isn’t helping. (AP Photo/John Locher)
1010 WINS Newsroom
June 05, 2020 - 12:34 pm
Leaders of a large study in the United Kingdom that is rigorously testing the malaria drug hydroxychloroquine and other medicines for hospitalized COVID-19 patients say they will stop putting people on the drug because it’s clear it isn’t helping. Results released Friday from 1,542 patients showed...
Read More
FILE - This April 7, 2020 file photo shows a bottle of hydroxychloroquine tablets in Texas City, Texas. Several authors of a large study that raised safety concerns about malaria drugs for coronavirus patients have retracted the report, saying independent reviewers were not able to verify information that’s been widely questioned by other scientists. A retraction in the journal Lancet on Thursday, June 4, 2020 involved a May 22 report on hydroxychloroquine and chloroquine, drugs long used for preventing or treating malaria but whose safety and effectiveness for COVID-19 are unknown. (AP Photo/David J. Phillip, File)
1010 WINS Newsroom
June 04, 2020 - 5:20 pm
Several authors of a large study that raised safety concerns about malaria drugs for coronavirus patients have retracted the report, saying independent reviewers were not able to verify information that’s been widely questioned by other scientists. Thursday’s retraction in the journal Lancet...
Read More
FILE - This Monday, April 6, 2020 file photo shows an arrangement of hydroxychloroquine pills in Las Vegas. On Tuesday, June 2, 2020, concerns are mounting about studies in two influential medical journals on drugs used in people with coronavirus, including one that led multiple countries to stop testing a malaria pill. (AP Photo/John Locher,File)
1010 WINS Newsroom
June 02, 2020 - 4:06 pm
Concerns are mounting about studies in two influential medical journals on drugs used in people with coronavirus, including one that led multiple countries to stop testing a malaria pill. The New England Journal of Medicine issued an “ expression of concern ” Tuesday on a study it published May 1...
Read More
Matt Hancock Britain's Secretary of State for Health is driven through the entrance to Parliament in London, Tuesday, June 2, 2020. The British government has decided to scrap a remote-voting system used during the coronavirus pandemic, and has summoned lawmakers back to parliament on Tuesday, but many aren't happy with the arrangements. (AP Photo/Frank Augstein)
1010 WINS Newsroom
June 02, 2020 - 2:03 pm
LONDON (AP) — People from ethnic minorities have died from COVID-19 in larger relative numbers in England than their white compatriots, according to a study published by health authorities Tuesday. The Public Health England report hinted at reasons for the discrepancy but didn't offer any...
Read More
FILE - This is an April 30, 2020, file photo showing Gilead Sciences headquarters in Foster City, Calif. A California biotech company says its experimental drug remdesivir improved symptoms when given for five days to moderately ill, hospitalized patients with COVID-19. Gilead Sciences gave few details on Monday, June 1, 2020, but said full results would soon be published in a medical journal. (AP Photo/Ben Margot, File)
1010 WINS Newsroom
June 01, 2020 - 11:53 am
A California biotech company says its experimental drug remdesivir improved symptoms when given for five days to moderately ill, hospitalized patients with COVID-19. Gilead Sciences gave few details on Monday but said full results would soon be published in a medical journal. Remdesivir is the only...
Read More
This microscope image made available by the National Cancer Institute Center for Cancer Research in 2015 shows human colon cancer cells with the nuclei stained red. On Friday, May 29, 2020, doctors are reporting success with newer drugs that control certain types of cancer better, reduce the risk it will come back and make treatment simpler and easier to bear. (NCI Center for Cancer Research via AP)
1010 WINS Newsroom
May 29, 2020 - 8:32 am
Doctors are reporting success with newer drugs that control certain types of cancer better, reduce the risk it will come back and make treatment simpler and easier to bear. Gentler drugs would be a relief to patients like Jenn Carroll, a 57-year-old human resources director from New Hartford,...
Read More
Motorcycles wearing face masks to help curb the spread of the new coronavirus wait at a stoplight in Bangkok, Thailand, Tuesday, May 26, 2020. (AP Photo/Sakchai Lalit)
1010 WINS Newsroom
May 26, 2020 - 7:38 am
BANGKOK (AP) — As about 24,000 Filipinos who lost their jobs abroad are being transported by land, sea or air to their provincial homes, the president warned local officials not to refuse them entry out of coronavirus fears. The workers returned to the country in recent months as jobs dried up...
Read More
1010 WINS Newsroom
May 25, 2020 - 8:35 pm
CANBERRA, Australia (AP) — A U.S. biotechnology company began injecting a coronavirus vaccine candidate into people in Australia on Tuesday with hopes of releasing a proven vaccine this year. Novavax will inject 131 volunteers in the first phase of the trial testing the safety of the vaccine and...
Read More
FILE - This Tuesday, April 7, 2020 file photo shows a bottle of hydroxychloroquine tablets in Texas City, Texas. The World Health Organization said Monday May 25, 2020, that it will temporarily drop hydroxychloroquine from its global study into experimental COVID-19 treatments because its experts need to review all available evidence. (AP Photo/David J. Phillip, File)
1010 WINS Newsroom
May 25, 2020 - 1:46 pm
GENEVA (AP) — The World Health Organization said Monday that it will temporarily drop hydroxychloroquine — the anti-malarial drug U.S. President Trump says he is taking — from its global study into experimental COVID-19 treatments, saying that its experts need to review all available evidence to...
Read More

Pages